| Margins | Mean ROI ranges from 8.56% to 18.9% across segments. |
|---|---|
| Management confidence | Balanced; transparent disclosure of disbursed interest rates. |
Growth
Interest rates for business loans peak at 25%, while secured products hover between 7.5% and 14.25%.
Outlook
N/A - document reflects historical rates for the Jan-Mar 2026 period.
Risks
High dispersion in Business Loan ROI (9.5%-25%) suggests varying risk profiles and potential asset quality stress.
Earnings Call filed with NSE, NSE: AXISBANK. Summary written with AI assistance from the document.
Axis Bank Ltd: key numbers
- Share price
- ₹1,331.00
- Market cap
- ₹4,14,537 Cr
- Revenue (annual)
- ₹1,32,538 Cr
- Net profit (annual)
- ₹26,385 Cr
- P/E (TTM)
- 13.8×Sector 21.0×
- Promoter holding
- 7.86%-0.01% QoQ
- FII holding
- 38.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Axis Bank Ltd
All →Axis Bank Other Announcement
Axis Bank disclosed a connected person's sale of 2,000 shares worth about Rs.0.27 Crore on 11 November 2026. The sale left the holder with nil shares.
- Value
- ₹0.27 Cr
Axis Bank Employee Stock Options
Axis Bank allotted 220,144 equity shares on November 11, 2026, under its ESOP/RSU scheme. The paid-up capital increased, with no cash value stated for the allotment.
Axis Bank Annual General Meeting
Axis Bank's postal ballot passed four resolutions, re-appointing two directors and appointing two others. The scrutinizer's report and voting results were filed on 6 November 2026.
Axis Bank Management Change
Axis Bank disclosed that Independent Director Girish Paranjpe ceased to be a director on completion of his tenure, effective close of business on 1 November 2026. No monetary value is involved in this change.
Axis Bank Employee Stock Options
Axis Bank granted 1,05,460 stock options at Rs.1,217 each under its ESOS 2000-01. Options vest over three years, exercisable within five years of vesting.
Axis Bank Legal & Regulatory
Axis Bank disclosed a SEBI censure order against subsidiary Axis Capital Limited. No investor harm or fraudulent design was involved.